Vineet Laboratories Share Price
37.64+0.14 (+0.37%)
+31.19% past 1 Year
Vineet Laboratories Limited (Formerly Known as Ortin Laboratories Limited) is incorporated in India on November 10, 2016. The company is engaged in the business of Drug Intermediates & Bulk Dugs.
Corporate filings & documents
Announcements
Updated Financial Results for the Quarter and Finacial year ended 31st March 2026
5 days agoUpdated Financial Results for the Quarter and Finacial year ended 31st March 2026
5 days agoThe Board of Director of the company in its meeting held on August 25 2026Approved the Audited Standalone Financial Results for the fourth quarter and the financial year ended on 31st march 2026and the audited Standalone Financial Statement for the financial year ended 31st March 2026 along with audit report
1 week agoThe Board of Director of the company in its meeting held on August 25 2026Approved the Audited Standalone Financial Results for the fourth quarter and the financial year ended on 31st march 2026and the audited Standalone Financial Statement for the financial year ended 31st March 2026 along with audit report
1 week agoThe Board of Directors of the company in its meeting held today i.e. on August 25 2026 has:Approved the Audited Standalone Financial Results of the Company for the fourth quarter and the financial year ended on 31 March 2026 and the Audited Standalone Financial Statement for the financial year ended on 31* March 2026 along with Audit Report.
1 week agoThe Board of Directors of the company in its meeting held today i.e. on August 25 2026 has:Approved the Audited Standalone Financial Results of the Company for the fourth quarter and the financial year ended on 31 March 2026 and the Audited Standalone Financial Statement for the financial year ended on 31* March 2026 along with Audit Report.
1 week agoVineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/08/2026 inter alia to consider and approve the Audited Standalone Financial Results of the Company for the Fourth Quarter and the Financial Year ended on March 31 2026.
2 weeks agoVineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/08/2026 inter alia to consider and approve the Audited Standalone Financial Results of the Company for the Fourth Quarter and the Financial Year ended on March 31 2026.
2 weeks agoPlease find the attached Monitoring Agency Report issued by CRISIL rating Limited for quarter ended June 30 2026
2 weeks agoPlease find the attached Monitoring Agency Report issued by CRISIL rating Limited for quarter ended June 30 2026
2 weeks agoWe are hereby submitting the compliance Certificate issued by Venture Capital and Corporate Inveatments Private Limited
1 month agoWe are hereby submitting the compliance Certificate issued by Venture Capital and Corporate Inveatments Private Limited
1 month agoWe are hereby informed that Mr. Gaddam Venkata Ramana ( DIN:00031873) has ceased to hold office of Managing Director of Vineet Laboratories with effect form July 21 2026. It further clarified that Mr. Gaddam Venkata Ramana continues to hold office as a Director of the company
1 month agoWe are hereby informed that Mr. Gaddam Venkata Ramana ( DIN:00031873) has ceased to hold office of Managing Director of Vineet Laboratories with effect form July 21 2026. It further clarified that Mr. Gaddam Venkata Ramana continues to hold office as a Director of the company
1 month agoAppointment of Rajesh Kumar Kathulla as an Additional Director (Executive Catagory) of the company with effect from 11th day of June 2026
1 month agoAppointment of Rajesh Kumar Kathulla as an Additional Director (Executive Catagory) of the company with effect from 11th day of June 2026
1 month agoIntimation regarding diferment of Board Meeting
1 month agoIntimation regarding diferment of Board Meeting
1 month agoVineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/07/2026 inter alia to consider and approve Audited Standalone Financial Results
1 month agoVineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/07/2026 inter alia to consider and approve Audited Standalone Financial Results
1 month agoOutcome of Board Meeting Held on May 30 2026 Deferment of Consideration of Audited Standalone Financial Results
3 months agoWe are hereby submitting the resignation of Company Secretary.
3 months agoWe are hereby submitting the resignation of Company Secretary.
3 months agoVineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve the Audited Standalone Financial Results of the Company for the Fourth Quarter and the Financial Year ended March 31st 2026.
3 months agoVineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve the Audited Standalone Financial Results of the Company for the Fourth Quarter and the Financial Year ended March 31st 2026.
3 months agoPlease find the attached Monitoring Agency Report issued by Crisil Rating Limited for the quarter ended March 31 2026
3 months agoPlease find the attached Monitoring Agency Report issued by Crisil Rating Limited for the quarter ended March 31 2026
3 months agoWe are hereby submitting the certificate issued by Venture Capital and Corporate Investments Private Limited in compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for Fourth quarter ended on 31st March 2026
4 months agoThe Trading window for dealing in securities of the Company will remain closed from 01st April 2026 till 48 hours after announcement of Standalone Audited Financial results for the Fourth Quarter and Financial year ending on 31st March 2026
5 months agoThe Trading window for dealing in securities of the Company will remain closed from 01st April 2026 till 48 hours after announcement of Standalone Audited Financial results for the Fourth Quarter and Financial year ending on 31st March 2026
5 months agoWe enclose herewith the copies of Un-audited standalone financial results of the company for the Third quarter and Nine months ended on December 31 2025 published in following Newspapers on February 16 20261. Financial Express (English Language)2. Nava Telangana (Telugu Language)
6 months agoThe Board of Directors in its meeting held today i.e on February 14 2026 has considered and approved the Unaudited Standalone Financial Results along with the Limited Review Report submitted by the Statutory Auditors for the Third Quarter ended on December 31 2025 .
6 months agoThe Board of Directors in its meeting held today i.e on February 14 2026 has considered and approved the Unaudited Standalone Financial Results along with the Limited Review Report submitted by the Statutory Auditors for the Third Quarter ended on December 31 2025 .
6 months agoThe Board of Directors of the company in its meeting held today i.e. Saturday February 14 2026 has: considered and approved the unaudited standalone financial results of the company for the third quarter and nine months ended on December 31 2025 along with the Limited Review Report submitted by the Statutory Auditors. approved the proposed payments and ratified advances made to certain vendors towards Quality Control equipment and Purified RO Water equipment i.e. for the purpose(s) not mentioned in the Rights Issue Letter of Offer dated December 17 2025. However these payments made in February 2026 are for the equipment to be installed in the new production facility which was mentioned in the Letter of Offer.
6 months agoThe Board of Directors of the company in its meeting held today i.e. Saturday February 14 2026 has: considered and approved the unaudited standalone financial results of the company for the third quarter and nine months ended on December 31 2025 along with the Limited Review Report submitted by the Statutory Auditors. approved the proposed payments and ratified advances made to certain vendors towards Quality Control equipment and Purified RO Water equipment i.e. for the purpose(s) not mentioned in the Rights Issue Letter of Offer dated December 17 2025. However these payments made in February 2026 are for the equipment to be installed in the new production facility which was mentioned in the Letter of Offer.
6 months agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Arjun Aggarwal
6 months agoVineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve unaudited standalone financial results of the Company for the Third quarter ended on December 31 2025 along with the Limited Review Report
6 months agoWe are hereby submitting the Voting results of Extra-Ordinary General Meeting of Vineet Laboratories Limited held on Saturday February 07 2026.
6 months agoWe are hereby submitting the proceedings of EGM of Vineet Laboratories Limited held on Saturday February 07 2026 through Video Conferencing (VC) / Other Audio-Visual Means (OAVM).
6 months agoWe are hereby submitting the trading approvals received from BSE and NSE vide their letters dated February 04 2026 for the Equity shares allotted under Rights Issue of the Company.
7 months agoWe are submitting copies of advertisements published by the Company today i.e. February 02 2026 in respect of matters relating to Basis of Allotment of Rights Issue of Equity Shares of the Company in the following newspapers: 1) Financial Express (English) - National Daily Newspaper with wide circulation 2) Jansatta (Hindi) - National Daily Newspaper with wide circulation 3) Nava Telangana (Telugu) - Regional language daily newspaper with wide circulation at the place where the registered office of the Company is situated.
7 months agoWe would like to inform that the Rights Issue Committee of the Board of Directors of Vineet Laboratories Limited ("the Company") has today i.e. February 02 2026 considered and approved the allotment of 99 87 258 Equity shares of face value of Rs. 10/- each on Rights basis at an Issue Price of Rs. 30/- per Equity share (including a premium of Rs. 20/- per Equity share).
7 months agoWe are hereby submitting the copies of the Addendum to the Letter of Offer dated December 17 2025 published today in the following newspapers: 1. Financial Express (English National Daily Newspaper with wide circulation) 2. Jansatta (Hindi National Daily Newspaper with wide circulation) 3. Nava Telangana (Telugu daily newspaper with wide circulation telugu being the regional language of Telangana where our registered office is situated.)
7 months agoWe are hereby submitting the Newspaper publication made in Financial Express and Nava Telangana regarding the notice of Extra-Ordinary General Meeting of the Company to be held on February 07 2026
7 months agoThe Rights Issue Committee of the Board of Directors in its meeting held on January 13 2026 has decided to extend the "Last date for On Market Renunciation" and the "Issue Closing date" for the benefit of the Investors. We are hereby submitting the revised dates.
7 months agoThe Extra-Ordinary General Meeting of the Company is being conducted on Saturday February 07 2026 at 11.00 A.M. We are hereby submitting the notice of the EGM.
7 months agoWe are hereby submitting the certificate issued by Venture Capital and Corporate Investments Private Limited in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the Third quarter ended on December 31 2025.
7 months agoThe Board of Directors of the company in its meeting held today i.e. on Wednesday January 07 2026 has approved:1. Notice of Extra - Ordinary General Meeting to obtain the approval of the shareholders for appointing Ms. Jasmin Kunal Tailor (DIN:10794164) as an Independent Director of the Company2. Cut-Off date as January 09 2026 Friday for ascertaining the members to whom notice of Extra-Ordinary General Meeting shall be sent and January 30 2026 Friday for determining the eligibility to vote by electronic means or in the general meeting.3. Remote E-Voting period begins on February 4 2026 Wednesday 09.00 A.M and concludes on February 6 2026 Friday 05.00 P.M
7 months agoWe are hereby submitting the Newspaper Advertisements published before the date of opening of the Rights Issue as required under Regulation 84(1) of SEBI (ICDR) Regulations 2018.
8 months agoThe Trading Window for dealing in the securities of the Company will remain closed from 01st January 2026 till 48 hours after the announcement of Standalone Un-audited Financial results for the Third Quarter ending on 31st December 2025
8 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
2025-12-23
Rights
13:12;30.0 (Rights ratio;Offer price)
Company details
Registered office
Sy.no. 11/ A3, Eshwaramma Nilayam Saheb Nagar Kurudu V I L L Chintalkunta, L B Nagar Hyderabad Telangana PIN: 500074 Tel No: 040-24128833 Fax No: NULL Email: [email protected] Internet: www.vineetlabs.co.in
Registrars
Aurum, Door No 4-50/P-II/57/4F&5F Plot No 57, 4th & 5th Floors, Jayabheri Enclave Phase - II, Gachibowli(Old Address:12-10-167, MIG- 167,Bharat Nagar Colony, Hyderabad – 500018.)Phone: +91-40-23818475/6Fax : +91-40-23868024Email: info@vccili Aurum, Door No 4-50/P-II/57/4F&5F Plot No 57 4th & 5th Floors Jayabheri Enclave Phase - II, Gachibowli PIN: Tel No: 23818475,23868257,35164910 Fax No: NULL Email: [email protected] Internet: www.vccipl.com
Management
Dilip Vishnu Acharekar, Chairman
Gaddam Venkata Ramana, Director
Satyanarayana Raju Bhupathiraju, Whole Time Director & CFO
Alluri Ranga Raju, Non Executive Director
Premananda Reddy Vennapusa, Non Executive Independent Director
Details
BSE 543298
NSE VINEETLAB
ISIN INE505Y01010